Cardiorenal Syndrome
Obesity medications can tackle metabolic cardiorenal disease
The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, cardiovascular disease and overall mortality are well known.
Obesity medications can tackle metabolic cardiorenal disease
In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, CVD and overall mortality.
Dietitians should take the lead in weight management for patients with kidney disease
Registered dietitian nutritionists caring for patients with chronic kidney disease are frequently challenged to help address multiple chronic diseases, comorbidities and acute issues to achieve goals for health and well-being.
Nephrologists can address inertia behind obesity care
Obesity is an important health issue for patients with chronic kidney disease, speeding its progression, contributing to disability and limiting access to organ transplantation. Up to now, nephrologists typically do not manage obesity.
Healio | Nephrology News & Issues adds new Editorial Advisory Board Members
Healio | Nephrology News & Issues recently added new members to its Editorial Advisory Board to expand its expertise in palliative care, pediatrics, vascular access, infection control and cardiorenal syndrome.
Obesity, more common now in young patients, adds to the burden of cardiorenal syndrome
The Cover Story this month in Healio/ Nephrology News & Issues focuses on obesity and its relationship to chronic kidney disease and ultimately, cardiovascular disease and death.
Kidney outcomes stable or improved in most patients after TAVR
More than 80% of patients who underwent transcatheter aortic valve replacement experienced stable or improved kidney outcomes 1 month after the procedure, researchers reported.
Southwest Nephrology-Cardio Renal Metabolic Conference focuses on inhibitors, dialysis and cross-specialty care
Under the leadership of President Peter McCullough, MD, The Cardio Renal Society of America’s mission is to prevent and manage three potentially chronic conditions that often coexist: kidney disease, cardiovascular disease and diabetes.
Part of the Healio Network
Cardiorenal Syndrome
The cardiorenal syndrome occurs when low cardiac output results in decreased renal perfusion and renal failure. The treatment is aimed at increasing cardiac output frequently by using cardiac inotropes such as dobutamine and milrinone.